682. Is There a Role for the Early Use of Tocilizumab and Interleukin-6 Levels in the Management of SARS-CoV-2 Patients with Early Respiratory Failure?

BACKGROUND: The severity of respiratory failure in SARS-CoV-2 infection appears to be related to cytokine release syndrome (CRS), resulting in mechanical ventilation (MV). In this observational study, we investigated tocilizumab’s role in the treatment of SARS-CoV-2 and the use of interleukin-6 (IL-...

Descripción completa

Detalles Bibliográficos
Autores principales: Antony, Suresh J, Almaghlouth, Nouf K, Davis, Monique G, Davis, Michelle A, Guevara, Roberto, Antony, Nishaal, Fahad, Omar, Prakash, Bharat, Del Rey, Fernando, Hassan, Ali, Arian, Muhammad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Poster Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7777726/
http://dx.doi.org/10.1093/ofid/ofaa439.874

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7777726/
http://dx.doi.org/10.1093/ofid/ofaa439.874

Ejemplares similares